ArticleExperimental dermatology2016

Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.

Peter Birner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.